fashion -WSS

fashion

author：entertainment 2025-10-02 14:39:18 - browse：9559

Sarepta - Cambridge -AP — A logo sign outside of the headquarters of Sarepta Therapeutics in Cambridge, Mass. Kristoffer Tripplaar/Sipa via AP

Reviewers at the Food and Drug Administration were leaning toward rejecting a closely watched gene therapy for Duchenne muscular dystrophy made by Sarepta Therapeutics, prompting a top official to intervene earlier this year, according to three people with direct knowledge of the agency deliberations.

Inside the FDA office that oversees gene therapies, some staff had reached a non-binding conclusion that Sarepta’s gene therapy should be rejected, the individuals said, speaking on condition of anonymity. Peter Marks, a top FDA official and vocal advocate for faster gene therapy approvals, stepped in and directed staff to schedule a public hearing on the therapy on May 12.

Sarepta announced the scheduling of the public hearing last month, but the internal deliberations that led to it have not been previously reported.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： Elisabeth Bik tackles the widespread issue of research misconduct

hotspot

explore

WSS

CDC panel: People 65 and older should get a Covid spring booster shot

Health care court cases: Humana, Sutter, Novant

Teladoc has a new CEO, but challenges remain the same

Study fuels hope CAR

Laying a path for careers in science

Change Healthcare cyberattack shows risk of industry consolidation

hotspot

fashion

hotspot

In Memoriam: Notable people who died in 2023

Redefining sustainability for the pharmaceutical industry

Wildfire smoke exposes gaps in outdoor worker protections

STAT Madness 2024: Meet the contenders

Medical records are filled with copy

FDA reviewers ask if approval of Lilly’s Alzheimer’s drug should be restricted

As demand for Covid shots wanes, Moderna seeks its next success

Deposition: Sackler embraced plan to conceal OxyContin’s strength

Novavax promises a turnaround & Lilly roils the obesity market

Medical device trials still don't enroll enough women, study finds

Wikipedia

California wildfire smoke linked to 52,000 early deaths, study says

Ohio train derailment: Experts on toxic chemical risks

How faith leaders like me can help address America's obesity epidemic

The system is set up to fail children with medical complexity

Doctor of U.S. President Joe Biden says he is fit for duty

Statins may not be needed by millions of people, study suggests

hotspot

hotspot

explore

hotspot